Clinical Trial Update: A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420. [Phase 1]

View source ↗

Summary

An early-phase dose-escalation and expansion trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7283420 in patients with ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• RO7283420

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED